WuXi Biologics (Cayman) Inc. (WXIBF)
OTCMKTS · Delayed Price · Currency is USD
5.20
0.00 (0.00%)
At close: Feb 11, 2026
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of $21.91 billion as of February 11, 2026. Its market cap has increased by 128.81% in one year.
Market Cap
21.91B
Enterprise Value
21.45B
Revenue
2.80B
Ranking
n/a
PE Ratio
37.41
Stock Price
$5.20
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 4.11B to 21.91B, an increase of 433.33%. That is a compound annual growth rate of 21.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 21.91B | 31.23% |
| Dec 31, 2025 | 16.70B | 79.88% |
| Dec 31, 2024 | 9.28B | -41.99% |
| Dec 29, 2023 | 16.00B | -50.63% |
| Dec 30, 2022 | 32.41B | -35.36% |
| Dec 31, 2021 | 50.14B | -7.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 304.50M |
| Silence Therapeutics | 213.03M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |